IL16 and non-small cell lung carcinoma: For IL-1ra, IL-16, IL-17A, macrophage migration inhibitory factor (MIF), granulocyte colony-stimulating factor (G-CSF) and MMP-2, the median serum concentration value in NSCLC patients was significantly lower compared with COPD patients.